| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2539297 | Fitoterapia | 2011 | 7 Pages |
Cytochrome P450 (CYP) enzyme inhibitory properties of six chromenylated amide compounds (CAs) from Amyris plumieri are described. Inhibition of CYP microsomes (CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 and CYP2C19) was monitored using a fluorescent assay. Potent inhibition was found against CYP1A1 with IC50 and Ki for CA1 (acetamide), being the lowest at 1.547 ± 1.0 μM and 0.37 μM respectively, displaying non-competitive kinetics. The selectivity for CYP1A1 was increased in CA3 (butanamide), which also exhibited cytotoxicity against breast cancer cells, MCF7 with an IC50 of 47.46 ± 1.62 μM. Structure–activity relationship studies provide insight at a molecular level for CAs with implications in chemoprevention and chemotherapy.
Graphical AbstractFigure optionsDownload full-size imageDownload as PowerPoint slide
